About Index Trending news
Analyze
Pricing
Oryzon Genomics

Oryzon Genomics

Work at Oryzon Genomics? Add yourself to this profile

Oryzon Genomics

Oryzon Genomics develops diagnostic and therapeutic tools based on identifiedbiomarker genes and proteins.

Elsewhere

Alexa global traffic share

Latest funding
Post-IPO equity
€18,000,000
Venture capital (Series B)
$17,024,700
Employees

Team size

200+
Locations
HQ
Headquarters
€18,000,000 Post-IPO equity
Marketwire , biotech-spain

Oryzon Raises EUR 18 Million through a Private Placement with US and European Investors